These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36349508)

  • 1. Is a specific T classification needed for extrahepatic intraductal papillary neoplasm of the bile duct (IPNB) type 2 associated with invasive carcinoma?
    Mitake Y; Onoe S; Igami T; Mizuno T; Yamaguchi J; Sunagawa M; Watanabe N; Kawakatsu S; Shimoyama Y; Ebata T
    J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):745-754. PubMed ID: 36349508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
    Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
    J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications.
    Kim JR; Lee KB; Kwon W; Kim E; Kim SW; Jang JY
    J Korean Med Sci; 2018 Oct; 33(42):e266. PubMed ID: 30310366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location.
    You Y; Choi SH; Choi DW; Heo JS; Han IW; Jang KT; Han S
    J Gastrointest Surg; 2020 Apr; 24(4):804-812. PubMed ID: 31062272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
    Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
    Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study.
    Wu X; Li B; Zheng C
    Eur J Med Res; 2023 Mar; 28(1):132. PubMed ID: 36945047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
    Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
    Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
    Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
    Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.
    Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y
    Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features and Long-Term Outcomes of Intraductal Papillary Neoplasms of the Intrahepatic Bile Duct.
    Kim WJ; Hwang S; Lee YJ; Kim KH; Park KM; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Kim MH; Lee SK; Seo DW; Park do H; Lee SS; Lee SG
    J Gastrointest Surg; 2016 Jul; 20(7):1368-75. PubMed ID: 26873016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Rocha FG; Lee H; Katabi N; DeMatteo RP; Fong Y; D'Angelica MI; Allen PJ; Klimstra DS; Jarnagin WR
    Hepatology; 2012 Oct; 56(4):1352-60. PubMed ID: 22504729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
    Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
    Kim JR; Jang KT; Jang JY
    Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.